Navigation Links
Northwest Biotherapeutics Raises Funding and Proceeds With Balance Sheet Restructuring
Date:7/7/2010

BETHESDA, M.D., July 7 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. ("NWBT" or the "Company") (OTC Bulletin Board: NWBO), developer of the DCVax® personalized cancer vaccines, announced today that during the second quarter it raised funding of $2.65 million from investors.  The funding included $1.75 million in purchases of restricted common stock of the Company (the "Common Stock") by a number of private investors, together with purchases of restricted Common Stock totaling $900,000 by SDS Capital and by Ms. Linda F. Powers, Chair of the Company's Board.  The Company also continued to make progress on restructuring of its balance sheet, through debt conversions and extensions with its largest debt holders.  The new investment by SDS Capital was part of a larger restructuring transaction with SDS.

The $1.75 million in purchases of Common Stock by private investors were made at a price of seventy-five cents ($0.75) per share, with ten percent (10%) warrant coverage.

The restructuring transaction with SDS Capital was undertaken pursuant to a Conversion and Extension Agreement, which included the conversion or extension of all outstanding debt held by SDS, as well as new investment of $250,000 by SDS.  Prior to this Agreement, SDS was the second largest holder of investment debt of the Company.

As previously reported, the Company already entered into an agreement with the Al Rajhi Group in March, 2010, for the extension of all outstanding debt held by Al Rajhi. The Al Rajhi Group is the largest holder of investment debt of the Company.


'/>"/>
SOURCE Northwest Biotherapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Northwest Biotherapeutics Announces Appointment of Robert A. Farmer to the Board of Directors
2. Northwest Biotherapeutics Announces Plans to De-list From AIM and Consolidate its Stock Market Listing in U.S.
3. Avantium to Deliver Flowrence System to Pacific Northwest National Laboratory (PNNL), USA
4. Dendreon Corporation CEO Mitchell H. Gold, M.D. Named Ernst & Young Entrepreneur of the Year(R) 2009 Award Finalist in the Pacific Northwest
5. Cell Therapeutics Presents Corporate Highlights at Invest Northwest Conference
6. Cell Therapeutics, Inc. (CTI) to Present at 8th Annual WBBA Invest Northwest Conference
7. Oncothyreon to present at Invest Northwest 2009
8. Sirius Genomics to Present at Invest Northwest Conference
9. Northwest Biotherapeutics Secures $700,000 Equity Financing
10. Pacific Northwest National Laboratories Becomes a GeneGo Center of Excellence
11. Northwest Biotherapeutics Settles Class Action Complaint, and SEC Investigation Closed Without Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
... is great satisfaction when theoretical work is eventually supported ... a team of Italian and US scientists when they ... fluid science experiment that is currently orbiting the Earth ... only launched a week ago, the scientists are already ...
... Bone Innovations, Inc. (SBi),a single-source provider of products, technology ... introduced its PRECISE SD(TM) Volar Distal,Radius Locking Plate system ... SD plate geometry is based on computer analysis of ... in the Hamann Todd,Osteological Collection at the Cleveland Museum ...
... XTL,Biopharmaceuticals Ltd. (NASDAQ: XTLB ; LSE: XTL; ... and Extraordinary General Meeting,("EGM") was postponed for one week ... absence of a quorum. The postponed AGM and EGM ... Science Park,Rehovot, Israel 76100 at 4:00 pm and 4:30pm, ...
Cached Biology Technology:Fluid theory confirmed by Foton 2Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures 2Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures 3Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures 4XTL Biopharmaceuticals Ltd. AGM / EGM Postponed Until October 2, 2007 2
(Date:11/18/2014)... --  News Highlights: , ... Partners Data Lake, an agile data and analytics ... allow researcher and clinicians to explore and develop ... of patients , The Partners Data Lake ... Partners system, breaking down physical barriers for collaboration ...
(Date:11/12/2014)... , Nov. 12, 2014 Crossmatch™, a ... that its U.are.U ® fingerprint readers have been ... in Central Mexico . The bakery ... to eliminate payroll issues caused by employees clocking in ... the U.are.U fingerprint readers, Montparnasse relied on paper timecards ...
(Date:11/7/2014)... conjunction with the Glendale and ... the Verdugos has announced the " GLENDALE - ... to keep the Verdugo Regional Crime Lab operational after its ... existence, the Lab has processed more than 400 DNA samples, ... "Because our number one priority is the wellbeing of ...
Breaking Biology News(10 mins):Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5Montparnasse Pasteleria Achieves Time and Attendance Transparency with Crossmatch U.are.U Fingerprint Readers 2Community Foundation Of The Verdugos Unveils Campaign To Fund Glendale-Burbank DNA Justice Project 2
... May 16, 2012 Cardium Therapeutics (NYSE Amex: CXM) ... Society of Gene & Cell Therapy (ASGCT) 15th Annual ... Convention Center in Philadelphia, PA. ... an important role in adenovector gene transfection (delivery) in ...
... SANTA CRUZ, CA--Researchers at the University of California, Santa Cruz, ... migrations of elephant seals have compiled one of the largest ... and diving behavior at sea in unprecedented detail. ... PLoS ONE focuses on the annual migrations of adult ...
... take on dangerous tasks every dayand starting this week, they will ... the Baltic Sea of underwater mines left over from as long ... will be among the biggest naval exercises in the Baltic Sea ... the two world wars. It,s all part of a day,s work ...
Cached Biology News:Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial 2Elephant seal tracking reveals hidden lives of deep-diving animals 2Elephant seal tracking reveals hidden lives of deep-diving animals 3Undersea warriors, undersea medicine: The future force 2
Corticoliberin...
Microlite 2+ Plate, round bottom; an irradiated, high binding surface with enhanced dynamic range, extra high reflectivity and minimal cross talk for low signal luminescent reactions....
... pressure regulator and pressurized syringe holder for any ... Steady flow rate Microinjecting Fine microliter ... be added to any new or existing perfusion ... even homemade. Connect to house air or a ...
...
Biology Products: